Leukotriene Receptor Antagonists in Allergic Eye Disease: A Systematic Review and Meta-analysis Jennie Gane, MBChB (Hons), MSc, Roger Buckley, BM BCh, MA, FRCS The Journal of Allergy and Clinical Immunology: In Practice Volume 1, Issue 1, Pages 65-74 (January 2013) DOI: 10.1016/j.jaip.2012.07.001 Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Figure 1 Flow chart shows the results of the search strategy. The Journal of Allergy and Clinical Immunology: In Practice 2013 1, 65-74DOI: (10.1016/j.jaip.2012.07.001) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Figure 2 Forest plot shows the difference in pooled mean change-from-baseline ocular symptom scores between patients receiving LTRA (montelukast) and those receiving placebo. The Journal of Allergy and Clinical Immunology: In Practice 2013 1, 65-74DOI: (10.1016/j.jaip.2012.07.001) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Figure 3 Forest plot showing difference in pooled mean change-from-baseline ocular symptom scores between patients receiving LTRA and those receiving oral antihistamine (AntiH1). The Journal of Allergy and Clinical Immunology: In Practice 2013 1, 65-74DOI: (10.1016/j.jaip.2012.07.001) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Figure 4 Forest plot showing difference in pooled mean change-from-baseline ocular symptom scores between patients receiving LTRA and oral antihistamine (AntiH1) and those receiving placebo. The Journal of Allergy and Clinical Immunology: In Practice 2013 1, 65-74DOI: (10.1016/j.jaip.2012.07.001) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions